JUNIPER PHARMACEUTICALS INC Deferred Revenue
JUNIPER PHARMACEUTICALS INC had Deferred Revenue of $6.14 million as of 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2018-03-09
- 2017-12-31: Deferred Revenue $6.14M.
- 2016-12-31: Deferred Revenue $5.62M.
- 2016-06-30: Deferred Revenue $6.23M.
- 2016-03-31: Deferred Revenue $6.17M.
| Period end | Deferred Revenue |
|---|---|
| 2017-12-31 | $6.14M 10-K · filed 2018-03-09 |
| 2016-12-31 | $5.62M 10-K · filed 2018-03-09 |
| 2016-06-30 | $6.23M 10-Q/A · filed 2016-11-14 |
| 2016-03-31 | $6.17M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $4.88M 10-K · filed 2017-03-07 |
| 2014-12-31 | $6.03M 10-K/A · filed 2016-11-14 |